Skip to main content

TWST Twist Bioscience Corporation

Healthcare

152.78 Close 10/30
Since 2024-12-02 +203.7%
Open
162.94
High
167.27
Low
148.00
Prev close
173.45
Volume
3.4M
Amplitude
11.11%
P/B
21.5
Revenue YoY (TTM)
+19.2%
52W 23.30 219.71

Is Twist Bioscience Corporation a buy? Fundamentals and valuation first

As of 2026-10-30

Growth: Good, Momentum: Strong; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Average; Price / book is Expensive.
TTM P/E -68.82 N/A
Price / book 21.49 96th percentile Expensive
Free-cash-flow yield (%) -0.97 41th percentile Average
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Neutral All 3 indicators are Average.
ROE, TTM (%) -30.67 22th percentile Average
Operating margin, TTM (%) -31.91 20th percentile Average
FCF margin, TTM (%) -21.57 23th percentile Average
Quality Factor Investing: A US Quality Value Backtest
Growth Good All 2 indicators are Good.
Revenue growth, TTM YoY (%) 19.19 73th percentile Good
Diluted EPS growth, TTM YoY (%) 52.05 77th percentile Good
Momentum Strong All 2 indicators are Top.
60-day return (%) 40.06 97th percentile Top
240-day return (%) 468.59 100th percentile Top
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Neutral 20-day dollar volume is Top, but 60-day annualized volatility is Lagging.
20-day dollar volume 462,981,898 97th percentile Top
60-day annualized volatility (%) 103.35 84th percentile Lagging
Factor Investing Explained: 10 Classic Factors in US Stocks

Twist Bioscience Corporation (TWST) today

2 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Twist Bioscience Corporation to every stock like it

AI finds several complementary traits of Twist Bioscience Corporation across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) peers and tracking

Watchlist

This page refreshes daily after the close. Add Twist Bioscience Corporation to your watchlist to track signal changes on your next visit.

Twist Bioscience Corporation (TWST) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 99.49%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
15 historical occurrences (since 2019-05-06)

Average forward return after Top-quintile 6-month momentum

20-day: Win 40%, Sample 15, Median -6.56%, Excess -6.93%, Beat mkt rate 46.7%

60-day: Win 46.7%, Sample 15, Median -5.43%, Excess -5.72%, Beat mkt rate 46.7%

120-day: Win 26.7%, Sample 15, Median -9.91%, Excess -3.22%, Beat mkt rate 33.3%

120 days after: historical avg +1.99%

20-day -8.03%
60-day -2.12%
120-day +1.99%
20-day
60-day
120-day
Win
40%
46.7%
26.7%
Sample
15
15
15
Median
-6.56%
-5.43%
-9.91%
Excess
-6.93%
-5.72%
-3.22%
Beat mkt rate
46.7%
46.7%
33.3%

Over 15 occurrences, 120-day forward avg gained 1.99%, lagged the market by 3.22 pts; win rate 26.7%.

Filed revenue acceleration

Active · now 19.19%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

11 historical occurrences (since 2020-11-27)

Average forward return after Filed revenue acceleration

20-day: Win 72.7%, Sample 11, Median +4.51%, Excess +5.24%, Beat mkt rate 54.5%

60-day: Win 63.6%, Sample 11, Median +12.72%, Excess +6.46%, Beat mkt rate 54.5%

120-day: Win 40%, Sample 10, Median -9.46%, Excess -10.07%, Beat mkt rate 40%

120 days after: historical avg -2.61%

20-day +7.04%
60-day +10.45%
120-day -2.61%
20-day
60-day
120-day
Win
72.7%
63.6%
40%
Sample
11
11
10
Median
+4.51%
+12.72%
-9.46%
Excess
+5.24%
+6.46%
-10.07%
Beat mkt rate
54.5%
54.5%
40%

Over 10 occurrences, 120-day forward avg declined 2.61%, lagged the market by 10.07 pts; win rate 40%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

15 times historically; 60-day forward avg +37.34%, win rate 85.7%, beating the market by +30.85 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

15 times historically; 60-day forward avg +6.29%, win rate 53.3%, beating the market by +5.12 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.